Adalimumab's (Humira) main mechanism of action:

Adalimumab (Humira) is a TNF-alpha inhibitor u2014 it binds to tumor necrosis factor-alpha and blocks its interaction with other cells, reducing systemic inflammation. It is the world's best-selling medication, used for rheumatoid arthritis, Crohn's disease, and ulcerative colitis.